We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


HORIBA Announces New Combined Raman Products with Cytoviva

HORIBA Announces New Combined Raman Products with Cytoviva content piece image
Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute

HORIBA Scientific, specialists in measurement and analysis solutions for research and industry and Raman spectroscopy, has announced combined products using leading technology from CytoViva, Inc. By combining HORIBA’s Raman microscopes with CytoViva’s Hyperspectral Imaging (HSI) microscopy module and Enhanced Darkfield (EDF) illumination, the aim is to make Raman analysis is faster and more powerful.

This innovative integration is of major interest for applications related to nanomaterials research, drug delivery, nanotoxicology studies and SERS nanoparticles characterization. Hyperspectral imaging microscopy allows rapid imaging across the sample with high sensitivity. Colored images generated from the spectra guide the user to easily locate nanoparticles and features of interest.

The patented CytoViva enhanced darkfield illumination improves the signal-to-noise ratio up to ten times over standard darkfield microscopes. The detection limit in size improves sufficiently to allow visualizing nanoparticles as small as 10 nm when isolated.

Raman spectroscopy is a powerful technology for research and industry and provides detailed information on sample properties such as chemical structure, phase, polymorphism, intrinsic material stress, contamination and impurities.

Integrating Raman with hyperspectral imaging and enhanced darkfield allows users to rapidly visualize the sample and target regions of interest. They can then leverage Raman measurements from the identical field of view to provide and confirm the chemical identify of nanoparticles or other sample elements.

“CytoViva’s innovative enhanced darkfield illumination and hyperspectral imaging are perfectly complemented by HORIBA’s world-leading Raman instrumentation,” said Dr. Andrew Whitley, Vice President and Global Director of Business Development for HORIBA Scientific. “Benefits of combined technologies far exceed the sum of their parts… in this case the chemical specificity afforded by Raman can be quickly targeted to individual nanoparticles which the CytoViva components localize within minutes or even seconds.”